AIMS/HYPOTHESIS: Although it is known that lipid metabolism plays a role in insulin resistance in type 2 diabetes and in obesity, the mechanism is still largely unknown. Apolipoprotein E (ApoE) regulates plasma lipid levels and also plays a role in the uptake of lipids into various tissues. To investigate whether the suppression of whole-particle lipoprotein uptake into tissues affects insulin responsiveness and the diabetic condition, we examined the effect of an ApoE (also known as Apoe) gene deletion in MKR mice, a mouse model of type 2 diabetes. METHODS: ApoE ( -/- ), MKR, ApoE ( -/- )/MKR and control mice were placed on a high-fat, high-cholesterol diet for 16 weeks. Glucose tolerance, serum insulin, blood glucose, insulin tolerance, tissue triacylglycerol content and atherosclerotic lesions were assessed. RESULTS: ApoE ( -/- )/MKR and ApoE ( -/- ) mice showed significantly improved blood glucose, glucose tolerance and insulin sensitivity. Reduced triacylglycerol content in liver and reduced fat accumulation in liver and adipose tissue were found in ApoE ( -/- )/MKR and ApoE ( -/- ) mice compared with control and MKR mice. ApoE ( -/- ) and ApoE ( -/- )/MKR mice demonstrated similarly large atherosclerotic lesions, whereas MKR and control mice had small atherosclerotic lesions. CONCLUSIONS/ INTERPRETATION: We demonstrated that ApoE deficiency abrogates insulin resistance in a mouse model of type 2 diabetes, suggesting that lipid accumulation in tissue is a major cause of insulin resistance in this mouse model.
AIMS/HYPOTHESIS: Although it is known that lipid metabolism plays a role in insulin resistance in type 2 diabetes and in obesity, the mechanism is still largely unknown. Apolipoprotein E (ApoE) regulates plasma lipid levels and also plays a role in the uptake of lipids into various tissues. To investigate whether the suppression of whole-particle lipoprotein uptake into tissues affects insulin responsiveness and the diabetic condition, we examined the effect of an ApoE (also known as Apoe) gene deletion in MKR mice, a mouse model of type 2 diabetes. METHODS:ApoE ( -/- ), MKR, ApoE ( -/- )/MKR and control mice were placed on a high-fat, high-cholesterol diet for 16 weeks. Glucose tolerance, serum insulin, blood glucose, insulin tolerance, tissue triacylglycerol content and atherosclerotic lesions were assessed. RESULTS:ApoE ( -/- )/MKR and ApoE ( -/- ) mice showed significantly improved blood glucose, glucose tolerance and insulin sensitivity. Reduced triacylglycerol content in liver and reduced fat accumulation in liver and adipose tissue were found in ApoE ( -/- )/MKR and ApoE ( -/- ) mice compared with control and MKR mice. ApoE ( -/- ) and ApoE ( -/- )/MKR mice demonstrated similarly large atherosclerotic lesions, whereas MKR and control mice had small atherosclerotic lesions. CONCLUSIONS/ INTERPRETATION: We demonstrated that ApoE deficiency abrogates insulin resistance in a mouse model of type 2 diabetes, suggesting that lipid accumulation in tissue is a major cause of insulin resistance in this mouse model.
Authors: Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer Journal: Proc Natl Acad Sci U S A Date: 2003-03-10 Impact factor: 11.205
Authors: H Kim; M Haluzik; O Gavrilova; S Yakar; J Portas; H Sun; U B Pajvani; P E Scherer; D LeRoith Journal: Diabetologia Date: 2004-12-15 Impact factor: 10.122
Authors: David B Savage; Cheol Soo Choi; Varman T Samuel; Zhen-Xiang Liu; Dongyan Zhang; Amy Wang; Xian-Man Zhang; Gary W Cline; Xing Xian Yu; John G Geisler; Sanjay Bhanot; Brett P Monia; Gerald I Shulman Journal: J Clin Invest Date: 2006-02-16 Impact factor: 14.808
Authors: Paul Cohen; Makoto Miyazaki; Nicholas D Socci; Aaron Hagge-Greenberg; Wolfgang Liedtke; Alexander A Soukas; Ratnendra Sharma; Lisa C Hudgins; James M Ntambi; Jeffrey M Friedman Journal: Science Date: 2002-07-12 Impact factor: 47.728
Authors: Christian Rask-Madsen; Erica Buonomo; Qian Li; Kyoungmin Park; Allen C Clermont; Oluwatobi Yerokun; Mark Rekhter; George L King Journal: Arterioscler Thromb Vasc Biol Date: 2012-03-15 Impact factor: 8.311
Authors: Elena V Galkina; Matthew Butcher; Susanna R Keller; Matthew Goff; Anthony Bruce; Hong Pei; Ian J Sarembock; John M Sanders; Melissa H Nagelin; Suseela Srinivasan; Rohit N Kulkarni; Catherine C Hedrick; Frank A Lattanzio; Anca D Dobrian; Jerry L Nadler; Klaus Ley Journal: Arterioscler Thromb Vasc Biol Date: 2011-12-22 Impact factor: 8.311
Authors: N Alikhani; R D Ferguson; R Novosyadlyy; E J Gallagher; E J Scheinman; S Yakar; D LeRoith Journal: Oncogene Date: 2012-04-02 Impact factor: 9.867
Authors: David L Morris; Kelsie E Oatmen; Tianyi Wang; Jennifer L DelProposto; Carey N Lumeng Journal: Obesity (Silver Spring) Date: 2012-01-17 Impact factor: 5.002
Authors: A D Dobrian; M A Hatcher; J J Brotman; E V Galkina; P Taghavie-Moghadam; H Pei; B A Haynes; J L Nadler Journal: J Endocrinol Date: 2015-08-18 Impact factor: 4.286